Researchers from Boston nonprofit MassBiologics say they have developed a promising new drug to prevent Lyme disease and hope to begin human studies as early as next year.At a State House briefing yesterday of legislators and their aides, Dr. Mark S. Klempner, the group’s executive vice chancellor, said the medicine is tentatively called Lyme PrEP because it is designed to provide pre-exposure prevention.

Source: r20.rs6.net